Skip to main content


Melanoma

Study results show Medicare payment rates for Mohs micrographic surgery more than double those of other procedures for…
A study presented at the ASCO-SITC Symposium assessed real-world health resource utilization across different…
A recent study found that multiple factors including insurance status, ethnicity, and individual providing the…
The National Comprehensive Cancer Network released updated guidelines for the treatment of basal cell skin cancer,…
An adjuvant combination regimen may improve the rate of relapse-free survival by 19% in patients with stage III BRAF-…
Recently published long-term survival data shows the benefits of combining two conventional therapies to treat patients…
Bristol-Myers Squibb’s immunotherapy drug Opdivo is a better and safer option than its older medicine Yervoy for…
People who carry a BsmI single-nucleotide polymorphism are twice as likely to develop nonmelanoma skin cancer as their peers with similar known risk factors, such as older age, male sex, and light…
Men who use phosphodiesterase type 5 inhibitors have a slightly increased risk of developing melanoma and basal cell…
Contrary to current guidelines, early melanoma patients under age 40 may be more suitable for sentinel lymph node…
Back to Top